From Multiple PAR1 Receptor/Protein Interactions to their Multiple Therapeutic Implications.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Current Topics in Medicinal Chemistry

• Publication date

  2015-09-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1568026615666150519103911PMID 25986685
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exploring the Phe-Gly Dipeptide-Derived Piperazinone Scaffold in the Search for Antagonists of the Thrombin Receptor PAR1

  2014cited by this paper
• Targeting A549 lung adenocarcinoma cell growth and invasion with protease‑activated receptor‑1 siRNA.

  2014cited by this paper
• A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis.

  2014cited by this paper
• Anticoagulation inhibits tumor cell-mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response.

  2014cited by this paper
• Himbacine-derived thrombin receptor antagonists: c7-spirocyclic analogues of vorapaxar.

  2014cited by this paper
• Prohibitin is involved in the activated internalization and degradation of protease-activated receptor 1.

  2014cited by this paper
• Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).

  2014cited by this paper
• Regulator of G Protein Signaling 2 (RGS2) and RGS4 Form Distinct G Protein-Dependent Complexes with Protease Activated-Receptor 1 (PAR1) in Live Cells

  2014cited by this paper
• The anticoagulant activated protein C (aPC) promotes metaplasticity in the hippocampus through an EPCR‐PAR1‐S1P1 receptors dependent mechanism

  2014cited by this paper
• Biased signalling and proteinase‐activated receptors (PARs): targeting inflammatory disease

  2014cited by this paper
• Quantitative phosphoproteomics unveils temporal dynamics of thrombin signaling in human endothelial cells.

  2014cited by this paper
• Novel oral anticoagulants in acute coronary syndrome.

  2013cited by this paper
• Protease-Activated Receptor 1 Inhibition by SCH79797 Attenuates Left Ventricular Remodeling and Profibrotic Activities of Cardiac Fibroblasts

  2013cited by this paper
• Neutrophil Elastase and Proteinase-3 Trigger G Protein-biased Signaling through Proteinase-activated Receptor-1 (PAR1)*

  2013cited by this paper
• Discovery of Octahydroindenes as PAR1 Antagonists.

  2013cited by this paper
• Noncanonical Matrix Metalloprotease-1-Protease-activated Receptor-1 Signaling Triggers Vascular Smooth Muscle Cell Dedifferentiation and Arterial Stenosis*

  2013cited by this paper
• Transactivation of the PAR1-PAR2 Heterodimer by Thrombin Elicits β-Arrestin-mediated Endosomal Signaling*

  2013cited by this paper
• Current antithrombotic agents for acute coronary syndromes: focus on bleeding risk.

  2013cited by this paper
• Protease‐activated receptor‐1 modulates hippocampal memory formation and synaptic plasticity

  2013cited by this paper
• Influence of endothelial cell protein C receptor on breast cancer development

  2013cited by this paper
• Thrombin regulation of synaptic transmission: implications for seizure onset.

  2013cited by this paper
• PAR1 contributes to influenza A virus pathogenicity in mice.

  2013cited by this paper
• Proteinase-activated receptors (PARs) – focus on receptor-receptor-interactions and their physiological and pathophysiological impact

  2013cited by this paper
• Regulation of Protease-activated Receptor 1 Signaling by the Adaptor Protein Complex 2 and R4 Subfamily of Regulator of G Protein Signaling Proteins*

  2013cited by this paper
• Coagulation factor Xa induces an inflammatory signalling by activation of protease-activated receptors in human atrial tissue.

  2013cited by this paper
• Highly functionalized 2-oxopiperazine-based peptidomimetics: an approach to PAR1 antagonists.

  2013cited by this paper
• Altered plasma fibrin clot properties in patients with digestive tract cancers: links with the increased thrombin generation.

  2013cited by this paper
• An Activated Protein C Analog Stimulates Neuronal Production by Human Neural Progenitor Cells via a PAR1-PAR3-S1PR1-Akt Pathway

  2013cited by this paper
• Channel-mediated astrocytic glutamate release via Bestrophin-1 targets synaptic NMDARs

  2013cited by this paper
• Protease-activated receptor 1 (PAR1) coupling to G(q/11) but not to G(i/o) or G(12/13) is mediated by discrete amino acids within the receptor second intracellular loop.

  2012cited by this paper
• PR3 and Elastase Alter PAR1 Signaling and Trigger vWF Release via a Calcium-Independent Mechanism from Glomerular Endothelial Cells

  2012cited by this paper
• &bgr;-Adrenergic Receptor Stimulation Transactivates Protease-Activated Receptor 1 via Matrix Metalloproteinase 13 in Cardiac Cells

  2012cited by this paper
• Suppression of Arterial Thrombosis Without Affecting Hemostatic Parameters With a Cell-Penetrating PAR1 Pepducin

  2012cited by this paper
• Design, synthesis and biological evaluation of new peptide-based ureas and thioureas as potential antagonists of the thrombin receptor PAR1.

  2012cited by this paper
• Safety of the novel protease-activated receptor-1 antagonist vorapaxar in Japanese patients with a history of ischemic stroke.

  2012cited by this paper
• Physiology, pharmacology, and therapeutic potential of protease-activated receptors in vascular disease.

  2012cited by this paper
• Genetic pathways linking hemostasis and cancer.

  2012cited by this paper
• Modulation of PAR1 signalling by benzimidazole compounds

  2012cited by this paper
• High-resolution crystal structure of human Protease-Activated Receptor 1 bound to the antagonist vorapaxar

  2012cited by this paper
• Defining the cellular repertoire of GPCRs identifies a profibrotic role for the most highly expressed receptor, protease‐activated receptor 1, in cardiac fibroblasts

  2012cited by this paper
• Vorapaxar in the secondary prevention of atherothrombotic events.

  2012cited by this paper
• Targeting proteinase-activated receptors: therapeutic potential and challenges

  2012cited by this paper
• Regulation of human protease‐activated receptor 1 (hPar1) gene expression in breast cancer by estrogen

  2012cited by this paper
• Antiplatelet and antithrombotic effect of F 16618, a new thrombin proteinase‐activated receptor‐1 (PAR1) antagonist

  2012cited by this paper
• The Association of Protease Activated Receptor 1 gene −506 I/D Polymorphism with Disease-Free Survival in Breast Cancer Patients

  2012cited by this paper
• Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46.

  2012cited by this paper
• Progesterone promotes focal adhesion formation and migration in breast cancer cells through induction of protease-activated receptor-1.

  2012cited by this paper
• Determinants of the specificity of protease‐activated receptors 1 and 2 signaling by factor Xa and thrombin

  2012cited by this paper
• Pharmacokinetics of the novel PAR-1 antagonist vorapaxar in patients with hepatic impairment

  2012cited by this paper
• Thrombin stimulation of inflammatory breast cancer cells leads to aggressiveness via the EGFR-PAR1-Pak1 pathway

  2012cited by this paper
• Protease‐activated receptor‐1 cleaved at R46 mediates cytoprotective effects

  2012cited by this paper
• Matrix metalloproteases and PAR1 activation.

  2011cited by this paper
• N-Linked Glycosylation Regulates Human Proteinase-activated Receptor-1 Cell Surface Expression and Disarming via Neutrophil Proteinases and Thermolysin

  2011cited by this paper
• Increased expression of protease-activated receptor 1 (PAR-1) in human leukemias.

  2011cited by this paper
• Granzyme K Activates Protease-Activated Receptor-1

  2011cited by this paper
• Activation of protease activated receptor 1 increases the excitability of the dentate granule neurons of hippocampus

  2011cited by this paper
• The Paradigm of G Protein Receptor Transactivation: A Mechanistic Definition and Novel Example

  2011cited by this paper
• Cytoprotective protein C pathways and implications for stroke and neurological disorders.

  2011cited by this paper
• Redox regulation of human protease-activated receptor-2 by activated factor X.

  2011cited by this paper
• Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through β-arrestin and dishevelled-2 scaffolds

  2011cited by this paper
• Induction of IL-13 production and upregulated expression of protease activated receptor-1 by RANTES in a mast cell line.

  2011cited by this paper
• Protease-Activated Receptor-1 Antagonist F 16618 Reduces Arterial Restenosis by Down-Regulation of Tumor Necrosis Factor α and Matrix Metalloproteinase 7 Expression, Migration, and Proliferation of Vascular Smooth Muscle Cells

  2011cited by this paper
• Pharmacology, biodistribution, and efficacy of GPCR-based pepducins in disease models.

  2011cited by this paper
• Oral antiplatelet therapy for atherothrombotic disease: current evidence and new directions.

  2011cited by this paper
• Tumor Progression Locus 2 Mediates Signal-Induced Increases in Cytoplasmic Calcium and Cell Migration

  2011cited by this paper
• A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsis

  2011cited by this paper
• Adaptor Protein Complex-2 (AP-2) and Epsin-1 Mediate Protease-activated Receptor-1 Internalization via Phosphorylation- and Ubiquitination-dependent Sorting Signals*

  2011cited by this paper
• Involvement of protein kinase C and RhoA in protease-activated receptor 1-mediated F-actin reorganization and cell growth in rat cardiomyocytes.

  2011cited by this paper
• Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.

  2011cited by this paper
• Structure, function and pathophysiology of protease activated receptors.

  2011cited by this paper
• Neuronal Protease-Activated Receptor 1 Drives Synaptic Retrograde Signaling Mediated by the Endocannabinoid 2-Arachidonoylglycerol

  2011cited by this paper
• Identification of an antithrombotic allosteric modulator that acts through helix 8 of PAR1

  2011cited by this paper
• PAR1 and PAR2 Couple to Overlapping and Distinct Sets of G Proteins and Linked Signaling Pathways to Differentially Regulate Cell Physiology

  2010cited by this paper
• Protease-activated receptor-1 down-regulates the murine inflammatory and humoral response to Helicobacter pylori.

  2010cited by this paper
• Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis.

  2010cited by this paper
• Antithrombotic activity of F 16618, a new PAR1 antagonist evaluated in extracorporeal arterio-venous shunt in the rat.

  2010cited by this paper
• Thrombin-activated receptors: promising targets for cancer therapy?

  2010cited by this paper
• Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma.

  2010cited by this paper
• Etk/Bmx Regulates Proteinase-Activated-Receptor1 (PAR1) in Breast Cancer Invasion: Signaling Partners, Hierarchy and Physiological Significance

  2010cited by this paper
• Parstatin suppresses ocular neovascularization and inflammation.

  2010cited by this paper
• PAR1- and PAR2-induced innate immune markers are negatively regulated by PI3K/Akt signaling pathway in oral keratinocytes

  2010cited by this paper
• Exploration of a new series of PAR1 antagonists.

  2010cited by this paper
• Kallikrein-related peptidases: proteolysis and signaling in cancer, the new frontier

  2010cited by this paper
• Sepsis in general surgery: the 2005-2007 national surgical quality improvement program perspective.

  2010cited by this paper
• Discovery and SAR of small molecule PAR1 antagonists.

  2010cited by this paper
• Mechanism of Down-regulation of RNA Polymerase III-transcribed Non-coding RNA Genes in Macrophages by Leishmania*

  2010cited by this paper
• Phosphoinositide 3-kinase induced activation and cytoskeletal translocation of protein kinase CK2 in protease activated receptor 1-stimulated platelets.

  2010cited by this paper
• Design, synthesis and biological evaluation of non-peptide PAR1 thrombin receptor antagonists based on small bifunctional templates: arginine and phenylalanine side chain groups are keys for receptor activity

  2010cited by this paper
• Thrombin receptor antagonists may become an important antiplatelet therapy for coronary artery disease.

  2010cited by this paper
• Crystal Structure of Thrombin Bound to the Uncleaved Extracellular Fragment of PAR1*

  2010cited by this paper
• Protease activated receptors 1 and 4 sensitize TRPV1 in nociceptive neurones

  2010cited by this paper
• Synergistic Induction of Mitogen-Activated Protein Kinase Phosphatase-1 by Thrombin and Epidermal Growth Factor Requires Vascular Endothelial Growth Factor Receptor-2

  2010cited by this paper
• Differential association modes of the thrombin receptor PAR1 with Gαil, Gα12, and β‐arrestin 1

  2010cited by this paper
• Thrombin Stimulation of Proteoglycan Synthesis in Vascular Smooth Muscle Is Mediated by Protease-activated Receptor-1 Transactivation of the Transforming Growth Factor β Type I Receptor*

  2010cited by this paper
• Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells.

  2010cited by this paper
• Protease-activated Receptor-1 (PAR1) Acts via a Novel Gα13-Dishevelled Axis to Stabilize β-Catenin Levels*

  2010cited by this paper
• A Novel Protease-activated Receptor-1 Interactor, Bicaudal D1, Regulates G Protein Signaling and Internalization*

  2010cited by this paper
• Thrombin Induces Macrophage Migration Inhibitory Factor Release and Upregulation in Urothelium: A Possible Contribution to Bladder Inflammation

  2010cited by this paper
• Genetic Variations in Angiogenesis Pathway Genes Predict Tumor Recurrence in Localized Adenocarcinoma of the Esophagus

  2010cited by this paper
• Protease-activated receptors in cardiovascular health and diseases.

  2009cited by this paper

• POLR1F promotes proliferation and stemness of anaplastic thyroid cancer by activating F2R/p38 MAPK signaling.

  2025cites this paper
• YKL-40 promotes chemokine expression following drug-induced liver injury via TF-PAR1 pathway in mice

  2023cites this paper
• Heterogeneity induced GZMA-F2R communication inefficient impairs antitumor immunotherapy of PD-1 mAb through JAK2/STAT1 signal suppression in hepatocellular carcinoma

  2022cites this paper
• Down‐regulation of endothelial protein C receptor promotes preeclampsia by affecting actin polymerization

  2020cites this paper
• A combined marker based on plasma D-dimer and serum albumin levels in patients with nasopharyngeal carcinoma is associated with poor survival outcomes in a retrospective cohort study

  2019cites this paper
• Multi-functionality of proteins involved in GPCR and G protein signaling: making sense of structure–function continuum with intrinsic disorder-based proteoforms

  2019cites this paper
• Nafamostat mesilate, a serine protease inhibitor, suppresses interferon‐gamma‐induced up‐regulation of programmed cell death ligand 1 in human cancer cells

  2018cites this paper
• Astroglia as a cellular target for neuroprotection and treatment of neuro‐psychiatric disorders

  2017cites this paper
• Investigating detailed interactions between novel PAR1 antagonist F16357 and the receptor using docking and molecular dynamic simulations.

  2017cites this paper
• RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation

  2017cites this paper
• PAR1 activation affects the neurotrophic properties of Schwann cells

  2017cites this paper
• PAR1 Scaffolds TGFβRII to Downregulate TGF-β Signaling and Activate ESC Differentiation to Endothelial Cells

  2016cites this paper
• Regulator of G protein signaling 8 inhibits protease-activated receptor 1/Gi/o signaling by forming a distinct G protein-dependent complex in live cells.

  2016cites this paper
• Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Convertases in HIV-Associated Neurocognitive Disorder

  2015cites this paper